4DX:ASX
4DMedical Ltd
2,30 AUD
arrow_downward
−0,22%(−0,0050) 1 d
16 nov., 14:27:35 GMT+11 · AUD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 4DX …
Öppen
2,30 AUD
Högt
2,32 AUD
Lågt
2,26 AUD
Börsvärde
1,38 md
Genomsn. vol.
5,10 mn
Volym
1,47 mn
52v högst
7,55 AUD
52v lägst
1,40 AUD
EPS
−0,38 AUD
Utestående aktier
602,34 mn
Antal anställda
181
Öppen
2,30 AUD
Högt
2,32 AUD
Lågt
2,26 AUD
Börsvärde
1,38 md
Genomsn. vol.
5,10 mn
Volym
1,47 mn
52v högst
7,55 AUD
52v lägst
1,40 AUD
EPS
−0,38 AUD
Utestående aktier
602,34 mn
Antal anställda
181
Nyheter och artiklar
Från webbkällor och nyhetspartner
Vietnam.vn
·
för 1 dag sedan
S&P 500 och Nasdaq avslutade sina fyra veckor långa förlustsviter.
TRT World
·
för 1 timme sedan
Anthropic heads to market with billions riding on AI's promise
Yahoo Finance Singapore
·
för 35 minuter sedan
Aebi Schmidt Holding (NasdaqGS:AEBI) Stock Fair Value Moves Lower After Soft Q3 And 2026 Cut
Profil
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Om 4DMedical Ltd
VdAndreas Fouras
Anställda181
Grundades2013
Huvudkontor-
SektorHealth Care
Bransch-
Webbplats4dmedical.com